DrugPatentWatch Database Preview
JATENZO Drug Profile
Try a free trial
See Plans and Pricing
When do Jatenzo patents expire, and when can generic versions of Jatenzo launch?
Jatenzo is a drug marketed by Clarus and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-four patent family members in nine countries.
The generic ingredient in JATENZO is testosterone undecanoate. There are sixty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.
Summary for JATENZO
| International Patents: | 24 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 46 |
| Clinical Trials: | 1 |
| Patent Applications: | 740 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | JATENZO at DailyMed |
Synonyms for JATENZO
| (17-beta)-3-Oxoandrost-4-en-17-yl undecanoate |
| (17|A)-17-[(1-| xoundecyl)oxy]androst-4-en-3-one |
| (17beta)-3-Oxoandrost-4-en-17-yl undecanoate |
| (1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl undecanoate |
| (1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadec-6-en-14-yl undecanoate |
| [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate |
| 17beta-Hydroxyandrost-4-en-3-one undecanoate |
| 3-Oxoandrost-4-en-17beta-yl undecanoate |
| 4-08-00-00981 (Beilstein Handbook Reference) |
| 5-.alpha.-Androstan-3-one, 17-.beta.-hydroxy-, undecanoate |
| 5-alpha-Androstan-3-one, 17-beta-hydroxy-, undecanoate |
| 5949-44-0 |
| 949T440 |
| AC1L22PV |
| AKOS016010255 |
| AN-11881 |
| Andriol |
| Andriol (TN) |
| Andriol Testocaps |
| Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta)- |
| Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17beta)- |
| Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-(17beta) |
| Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17.beta.)- |
| Aveed |
| BAY 86-5037 |
| BCP11921 |
| BRN 3176734 |
| C-22555 |
| CC-34823 |
| CHEBI:135741 |
| CHEMBL2107067 |
| CLR-610 |
| CS-4342 |
| D06087 |
| EINECS 227-712-6 |
| GS-6598 |
| H16A5VCT9C |
| HY-B0626 |
| LS-148824 |
| MFCD00468114 |
| Nebido |
| Nebido-R |
| Org 538 |
| ORG-538 |
| Pantestone |
| Reandron 1000 |
| Restandol |
| Rextoro |
| SC-16124 |
| SCHEMBL147620 |
| T undecanoate |
| Testosterone (undecanoate) |
| Testosterone undecanoate |
| Testosterone undecanoate (USAN) |
| Testosterone undecanoate [USAN] |
| Testosterone Undeconate |
| Testosterone undecylate |
| Testosterone, undecanoate |
| Testosterone, undecanoate (ester) |
| UDSFVOAUHKGBEK-CNQKSJKFSA-N |
| Undestor |
| UNII-H16A5VCT9C |
| W-105318 |
| ZINC8214690 |
US Patents and Regulatory Information for JATENZO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-003 | Mar 27, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-002 | Mar 27, 2019 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-003 | Mar 27, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Clarus | JATENZO | testosterone undecanoate | CAPSULE;ORAL | 206089-001 | Mar 27, 2019 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for JATENZO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2008537960 | ➤ Sign Up |
| Japan | 5887044 | ➤ Sign Up |
| Russian Federation | 2429850 | ➤ Sign Up |
| Japan | 6251713 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2006113505 | ➤ Sign Up |
| Russian Federation | 2007142204 | ➤ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
